Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies

BMC Cancer201717:871

https://doi.org/10.1186/s12885-017-3902-4

Received: 31 December 2016

Accepted: 8 December 2017

Published: 19 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Dec 2016 Submitted Original manuscript
2 Apr 2017 Reviewed Reviewer Report - Nial J Wheate
3 Apr 2017 Reviewed Reviewer Report - Oliver Dorigo
28 Apr 2017 Author responded Author comments - sheng zhang
Resubmission - Version 2
28 Apr 2017 Submitted Manuscript version 2
3 May 2017 Reviewed Reviewer Report - Nial J Wheate
18 Aug 2017 Reviewed Reviewer Report - Justin Brown
26 Sep 2017 Author responded Author comments - sheng zhang
Resubmission - Version 3
26 Sep 2017 Submitted Manuscript version 3
29 Sep 2017 Reviewed Reviewer Report - Justin Brown
1 Dec 2017 Author responded Author comments - Fei Liang
Resubmission - Version 4
1 Dec 2017 Submitted Manuscript version 4
Publishing
8 Dec 2017 Editorially accepted
19 Dec 2017 Article published 10.1186/s12885-017-3902-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Shanghai Cancer Center and Shanghai Medical College, Fudan University, Shanghai, China
(2)
Rizhao City Hospital of Traditional Chinese Medicine, Rizhao, China
(3)
Department of clinical biochemistry, School of public health Taishan medical university, Taishan, China
(4)
Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China

Advertisement